The U.S. COVID-19 vaccination program has gone from zero to 50% in less than six months. As of Tuesday afternoon, the Biden administration said, half of the country's adults are now fully vaccinated against the coronavirus.Read More
The Food and Drug Administration says it's now OK to store the Pfizer COVID-19 vaccine at normal refrigerator temperatures for up to a month. This is much longer than was previously allowed under the FDA's emergency authorization and will make storage and distribution of the vaccine easier.Read More
The Food and Drug Administration said Monday that children 12 to 15 years old are now eligible to receive a key COVID-19 vaccine as the agency expanded its emergency use authorization for the Pfizer/BioNTech vaccine.Read More
New clinical trials showed that Pfizer's COVID-19 vaccine elicits "100% efficacy and robust antibody responses" in adolescents from 12 to 15 years old, the drug company announced Wednesday. The trial included 2,260 participants; the results are even better than earlier responses from participants ages 16 to 25.Read More
The new guidance is specific to freedoms that vaccinated people can resume in their own homes, but the agency warns that everyone – even those who are vaccinated – should continue to follow recommended guidelines in public settings, including masking.Read More
As the newest coronavirus vaccine makes its debut, the American public has a new set of deliberations before walking into their vaccine clinic — go with the new arrival or stick with the two vaccines that have already gone into the arms of more than 50 million Americans?Read More
A third COVID-19 vaccine is on the way, and this one requires only one shot for immunization. The Food and Drug Administration authorized Johnson & Johnson's vaccine for emergency use Saturday, a day after a panel of advisers to the agency voted unanimously (22-0) in its favor.Read More
In clinical trials, the Johnson & Johnson vaccine appears to be 66% effective at preventing moderate to severe cases of COVID-19 — compared to about 95% for Moderna and Pfizer. That has some people wondering if they should avoid the Johnson & Johnson vaccine. Absolutely not, says Dr. Ashish Jha, dean of the Brown University School of Public Health.Read More
Vaccine supply chains are extremely specialized and sensitive, relying on expensive machinery, highly trained staff and finicky ingredients. Manufacturers have run into intermittent shortages of key materials, according to the U.S. Government Accountability Office; the combination of surging demand and workforce disruptions from the pandemic has caused delays of four to 12 Read More
President Biden has finalized deals to buy 200 million more COVID-19 vaccine doses from Pfizer and Moderna by the end of July, increasing the likelihood of delivering on his promise to have all Americans inoculated by mid-summer.Read More
President Biden announced Tuesday that his administration is working to purchase an additional 200 million doses of the two COVID-19 vaccines that have been authorized for emergency use, with the goal, the White House says, of having enough vaccine supply for the entire adult U.S. population by the end of the summer.Read More
As reports emerge across the country of health facilities throwing out unused and spoiled COVID-19 vaccines, some state governments are failing to track the wastage as required by the Centers for Disease Control and Prevention, leaving officials coordinating immunization efforts blind to exactly how many of the precious, limited doses are going into the trash and why.Read More
Operation Warp Speed, the Trump administration's push to make a COVID-19 vaccine available in record time, added $628 million to a federal contract with Emergent BioSolutions, a Maryland-based contract manufacturer, "to advance manufacturing capabilities and capacity for a potential COVID-19 vaccine as well as therapeutics," the Department of Health and Human Services Read More
The group of Western scientists that reviews Covid vaccine decisions made by the Food and Drug Administration has approved the new Moderna vaccine. Washington Gov. Jay Inslee announced Sunday the Western States Scientific Safety Review Workgroup has voted unanimously to put this second vaccine on the market.Read More
On Friday, just one week after Pfizer and BioNTech's COVID-19 vaccine received a federal green light, the Food and Drug Administration formally authorized a second vaccine for emergency use — this one developed by Moderna. The biotech upstart won authorization for use in adults following extensive federal analysis of the vaccine, which the FDA found to be 94% effective at Read More
Vice President Pence, second lady Karen Pence and Surgeon General Jerome Adams received a COVID-19 vaccine on Friday at the White House in a televised event aimed at showing the vaccine is safe and effective.Read More
Hospitals in Washington and Idaho began to receive shipments of Pfizer’s COVID-19 vaccine on Monday, with distribution to certain groups of health care workers and long-term care residents expected to begin Tuesday.Read More
The first doses of Pfizer’s coronavirus vaccine should start arriving in Washington on Monday, with the first vaccinations of front line health care workers beginning as early as Tuesday. An upbeat Washington Gov. Jay Inslee announced that timeline at a rare Sunday news conference.Read More
Army Gen. Gustave Perna told reporters that distribution of the vaccine from Pfizer and BioNTech has begun, with shipment to 636 sites scheduled to begin on Monday. Read More
Pew Research Center found 83% of Asian Americans said they would get a vaccine compared to 42% of Blacks. White and Latinx respondents were about even with 63% and 61% respectively saying they would.Read More
Washington’s plan, devised by the state Department of Health, will be implemented by a 25-person Vaccine Planning and Coordination Team consisting of employees from within the department, sourcing from the Offices of Immunization and Child Profile, Emergency Preparedness and Response, Health Promotion and Education and others.Read More
The vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30,000 people.Read More
Pfizer's COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use. Read More
